146 related articles for article (PubMed ID: 35259410)
21. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
[TBL] [Abstract][Full Text] [Related]
22. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
[TBL] [Abstract][Full Text] [Related]
23. Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Macnaughton H; Nothnagle M; Early J
Am Fam Physician; 2021 Apr; 103(8):473-480. PubMed ID: 33856168
[TBL] [Abstract][Full Text] [Related]
24. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
el-Refaey H; Templeton A
Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
[TBL] [Abstract][Full Text] [Related]
25. Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial.
Iyengar K; Paul M; Iyengar SD; Klingberg-Allvin M; Essén B; Bring J; Soni S; Gemzell-Danielsson K
Lancet Glob Health; 2015 Sep; 3(9):e537-45. PubMed ID: 26275330
[TBL] [Abstract][Full Text] [Related]
26. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
Fox MC; Creinin MD; Harwood B
Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
[TBL] [Abstract][Full Text] [Related]
27. Telephone follow-up after early medical abortion using Australia's first low sensitivity urine pregnancy test.
Melville C; Goldstone P; Moosa N
Aust N Z J Obstet Gynaecol; 2023 Dec; 63(6):797-802. PubMed ID: 37452451
[TBL] [Abstract][Full Text] [Related]
28. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
Contraception; 2023 May; 121():109962. PubMed ID: 36736715
[TBL] [Abstract][Full Text] [Related]
29. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
30. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
32. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
[TBL] [Abstract][Full Text] [Related]
33. A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.
Dzuba IG; Chong E; Hannum C; Lichtenberg ES; Lugo Hernández EM; Ngoc NTN; Patel A; Rzayeva G; Sanhueza Smith P; Tsertsvadze G; Winikoff B
Contraception; 2020 May; 101(5):302-308. PubMed ID: 32014520
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
35. Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial.
Constant D; Harries J; Daskilewicz K; Myer L; Gemzell-Danielsson K
PLoS One; 2017; 12(6):e0179600. PubMed ID: 28640845
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
Moseson H; Jayaweera R; Egwuatu I; Grosso B; Kristianingrum IA; Nmezi S; Zurbriggen R; Bercu C; Motana R; Gerdts C
Obstet Gynecol; 2023 Aug; 142(2):330-338. PubMed ID: 37411022
[TBL] [Abstract][Full Text] [Related]
37. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
[TBL] [Abstract][Full Text] [Related]
38. Serum hCG threshold to assess medical abortion success.
Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: A retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador.
Moseson H; Bullard KA; Cisternas C; Grosso B; Vera V; Gerdts C
Contraception; 2020 Aug; 102(2):91-98. PubMed ID: 32360817
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
